217 related articles for article (PubMed ID: 28769871)
1. The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer's Disease.
Zhao J; Yue D; Zhou Y; Jia L; Wang H; Guo M; Xu H; Chen C; Zhang J; Xu L
Front Neurol; 2017; 8():342. PubMed ID: 28769871
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
3. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
Dehghani R; Rahmani F; Rezaei N
Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
6. Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer's disease.
Zheng BW; Yang L; Dai XL; Jiang ZF; Huang HC
Neurol Res; 2016 Feb; 38(2):177-86. PubMed ID: 27078700
[TBL] [Abstract][Full Text] [Related]
7. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
8. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Beta and MicroRNAs in Alzheimer's Disease.
Amakiri N; Kubosumi A; Tran J; Reddy PH
Front Neurosci; 2019; 13():430. PubMed ID: 31130840
[TBL] [Abstract][Full Text] [Related]
10. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
11. Sleep in Alzheimer's Disease - Beyond Amyloid.
Holth J; Patel T; Holtzman DM
Neurobiol Sleep Circadian Rhythms; 2017 Jan; 2():4-14. PubMed ID: 28217760
[TBL] [Abstract][Full Text] [Related]
12. Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease.
Tapia-Rojas C; Inestrosa NC
Neural Regen Res; 2018 Oct; 13(10):1705-1710. PubMed ID: 30136680
[TBL] [Abstract][Full Text] [Related]
13. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
14. [β Amyloid Hypothesis in Alzheimer's Disease:Pathogenesis,Prevention,and Management].
Zhang H; Zheng Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):702-708. PubMed ID: 31699204
[TBL] [Abstract][Full Text] [Related]
15. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
16. Subthreshold Amyloid Predicts Tau Deposition in Aging.
Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
[TBL] [Abstract][Full Text] [Related]
17. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
Tapia-Rojas C; Inestrosa NC
J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
[TBL] [Abstract][Full Text] [Related]
19. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
